Isomorphic Labs raises $5 billion to take AI-designed drugs towards clinical trials
The latest funding round comes six months after the company secured $2.1 billion, with Alphabet and existing investors participating again
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

